Jung Hwa Lim

Title: Jung Hwa Lim: Biomedical Inventions and Research

Introduction

Jung Hwa Lim is a woman inventor based in Daejeon, South Korea. Her work includes inventions in biomedical research, including cell-culture systems and therapeutic angiogenesis. She is associated with the Korea Research Institute of Bioscience and Biotechnology and is credited with 3 patents.

Latest Patents

Lim’s listed patents include “Biomimetic Cell Culture Apparatus and Cell Culture System Comprising the Same.” The invention describes culture units connected by a conduit to create a circulating path for culture medium. A pump drives the medium through the units, while an agitating module helps reproduce interactions among organs in the human body.

Another listed patent is “Method for Therapeutic Angiogenesis.” It describes regulating UCP activity or levels to affect VHL and, in turn, influence angiogenesis or cancer-cell proliferation and metastasis. The disclosure discusses increasing angiogenesis through UCP overexpression, which reduces endogenous VHL and stabilizes HIF-1α, supporting VEGF activation. It also describes potential applications in developing angiogenesis inducers and anticancer agents.

Career Highlights

Lim’s patent work reflects an interest in biomedical technologies that model biological systems and investigate mechanisms relevant to disease and tissue growth. Her affiliation with the Korea Research Institute of Bioscience and Biotechnology places this work within a research-focused institutional setting.

Collaborations

The provided information identifies Kyung-Sun Hwang and Cho-Rok Jung as Lim’s coworkers. It does not specify their roles in the listed patents or describe particular joint projects.

Conclusion

Jung Hwa Lim’s listed inventions span biomimetic cell-culture technology and a method for regulating pathways associated with angiogenesis and cancer, highlighting the biomedical focus of her patent portfolio.